Diabetes Care Devices - Switzerland

In Switzerland, revenue in the Diabetes Care Devices market market is projected to reach US$265.50m in 2024.
The revenue in this sector is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 12.01%, leading to a market volume of US$468.20m by 2029.
In a global context, the highest revenue will be generated the United States, which is expected to reach US$11.71bn in 2024.
Switzerland's diabetes care device market is increasingly focusing on innovative digital solutions, enhancing patient monitoring and improving overall management of chronic conditions.

Definition:
The Diabetes Care Devices market, a medical technology market, includes medical devices used in the management and treatment of diabetes. These devices range from blood glucose meters and continuous glucose monitoring systems to insulin pumps, insulin pens, and other related accessories. It is important to note that the market does not include pharmaceutical products used in the treatment of diabetes, such as insulin and oral hypoglycemic agents.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Medtronic, Abbott Laboratories, and Roche Diagnostics. Further information on the key players can be found in the Market Shares boxes.

Blood glucose monitoring devices
Insulin delivery devices

Diabetes drugs
Diabetes supplements

The Diabetes Care Devices Market in Switzerland is witnessing considerable growth, fueled by advancements in technology, increasing prevalence of diabetes, and heightened consumer awareness about health management and preventive care options.

Customer preferences: In Switzerland, there is a notable shift towards personalized diabetes management solutions, as consumers increasingly prefer devices that offer tailored insights and data analytics. This trend is influenced by the growing emphasis on self-care and proactive health management, particularly among younger demographics. Additionally, the rise of telehealth services is reshaping access to diabetes care, enabling patients to connect with healthcare professionals remotely. Cultural values emphasizing innovation and quality also drive the demand for advanced technologies that enhance lifestyle integration and simplify diabetes management.

Trends in the market: In Switzerland, the Diabetes Care Devices Market is experiencing an increasing demand for integrated digital health solutions, with a focus on continuous glucose monitoring (CGM) and insulin delivery systems that provide real-time data and analysis. This trend is driven by a surge in health-conscious consumers seeking tools that facilitate personalized diabetes management. Furthermore, the integration of artificial intelligence in these devices is enhancing predictive insights, allowing for better decision-making. The emphasis on patient empowerment and proactive health management is reshaping the landscape, prompting industry stakeholders to invest in innovative technologies that improve user experience and adherence to treatment plans.

Local special circumstances: In Switzerland, the Diabetes Care Devices Market is shaped by a robust healthcare system and high consumer awareness regarding health and wellness. The country’s strong regulatory framework ensures the quality and efficacy of medical devices, fostering trust among users. Additionally, the culturally ingrained emphasis on preventive health measures drives demand for advanced diabetes management solutions. The mountainous geography also influences lifestyle choices, leading to a preference for devices that seamlessly integrate with active lifestyles, thereby enhancing adherence to treatment protocols and overall health outcomes.

Underlying macroeconomic factors: The Diabetes Care Devices Market in Switzerland is influenced by several macroeconomic factors, including national economic health and global market trends. Switzerland’s strong GDP and low unemployment rates contribute to higher disposable incomes, enabling consumers to invest in advanced diabetes management technologies. Furthermore, the country’s proactive fiscal policies support healthcare innovation and research, fostering an environment conducive to the development of cutting-edge diabetes care devices. Global trends, such as the rising prevalence of diabetes and increasing healthcare awareness, also drive demand, ensuring sustained growth in this sector as consumers seek effective solutions for disease management and prevention.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.